Paul Daruwala, Chief Operating Officer at Cidara Therapeutics, Inc. (CDTX), sold 2,240 shares at $2.55 ($6K) on 2019-03-07, disclosed to the SEC on 2019-03-08.
Open-market sale of $6k CDTX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CDTX | SELL | 2021-04-05 | $7K | — | Filing → |
| CDTX | SELL | 2020-06-25 | $3K | — | Filing → |
| CDTX | SELL | 2020-01-06 | $8K | — | Filing → |